Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 1,3211,340 of 20,252 grants

Completed OTHERS
PROTECT - Develop therapeutics to target oncogenic drivers of solid tumours in children
NATIONAL CANCER INSTITUTE The Institute of Cancer Research: Royal... United Kingdom 2024 – 2025

Title: PROTECT – Harnessing PROTEin degradation for Advanced Childhood Tumors Abstract: Background Survival rates for children with solid tumors, including brain, have largely plat...

$1.29M
USD
Completed OTHER RESEARCH-RELATED
Imaging zinc secretion from the exocrine pancreas for the early diagnosis of pancreatic adenocarcinoma with MRI
NATIONAL CANCER INSTITUTE Massachusetts General Hospital United States 2024 – 2024

ABSTRACT This proposal aims to use noninvasive molecular magnetic resonance (MR) imaging of pancreatic zinc content and secretion to detect pancreatic intraepithelial neoplasia (Pa...

$700K
USD
Completed NON SBIR/STTR CONTRACTS
CLINICAL TRIALS MONITORING SERVICE
NATIONAL CANCER INSTITUTE Theradex Systems, Inc United States 2024 – 2025

This is a Research and Development Support contract.The purpose of this acquisition is to assist the NCI in fulfilling its responsibilities to the Food and Drug Administration (FDA...

$82.46M
USD
Completed RESEARCH CENTERS
Cancer Genome & Epigenetics
NATIONAL CANCER INSTITUTE Sanford Burnham Prebys Medical Discovery... United States 2024 – 2025

The overall goals of the Cancer Genome & Epigenetics (CGE) Program (formerly Tumor Initiation and Maintenance Program) are to identify the cells that give rise to tumors and th...

Completed RESEARCH CENTERS
Cancer Metabolism & Microenvironment
NATIONAL CANCER INSTITUTE Sanford Burnham Prebys Medical Discovery... United States 2024 – 2025

The overall goal of the Cancer Metabolism & Microenvironment (CMM) Program (formerly Cell and Molecular Biology of Cancer Program) is to generate new knowledge about potential...

Completed RESEARCH CENTERS
Cancer Molecular Therapeutics
NATIONAL CANCER INSTITUTE Sanford Burnham Prebys Medical Discovery... United States 2024 – 2025

The overall goals of the Cancer Molecular Therapeutics (CMT) Program (formerly Aging, Cancer and Immuno-oncology (ACI)) are to engage active collaborations among members of the pro...

Completed RESEARCH CENTERS
American Indian/Alaskan Native Think Tank
NATIONAL CANCER INSTITUTE University of Utah United States 2024 – 2025

ABSTRACT Huntsman Cancer Institute (HCI) has set out to deliver a cancer-free frontier across the Mountain West and beyond. Our Cancer Center’s impact extends throughout the 5-stat...

$999.8K
USD
Active NON-SBIR/STTR RPGS
DNA Repair Deficiencies in Infertile Men and Cancer Risk
NATIONAL CANCER INSTITUTE Children'S Mercy Hosp (Kansas City, Mo United States 2024 – 2029

There is a need to identify the causes of the most severe form of male infertility, non-obstructive azoospermia (NOA), where there is spermatogenic failure resulting in an ejaculat...

$6.14M
USD
Completed RESEARCH CENTERS
Cancer Center Administration
NATIONAL CANCER INSTITUTE University of Utah United States 2024 – 2025

ADMINISTRATION ABSTRACT Huntsman Cancer Institute (HCI) Administration supports the Cancer Center’s mission to provide excellence in innovative basic, translational, population sci...

Active NON-SBIR/STTR RPGS
Elucidating alternative polyadenylation regulation during prostate cancer progression to castration-resistance
NATIONAL CANCER INSTITUTE Duke University United States 2024 – 2029

Project Summary/Abstract Alternative polyadenylation (APA) is a major mechanism of posttranscriptional regulation that generates distinct 3′ untranslated regions (3′UTR) on RNA tra...

$6.91M
USD
Completed TRAINING, INDIVIDUAL
Ribonucleotide Reductase as a Driver of Breast Cancer Aggressiveness
NATIONAL CANCER INSTITUTE Cleveland Clinic Lerner Com-Cwru United States 2024 – 2026

PROJECT SUMMARY Despite the vast improvement in screening techniques and therapies, breast cancer remains the second leading cause of cancer deaths in females worldwide. Approximat...

$486.8K
USD
Active OTHER RESEARCH-RELATED
Evaluating, Preparing, and Responding to Care Disruptions and Health Outcomes Among Patients with Breast Cancer Following Severe Storms
NATIONAL CANCER INSTITUTE Rutgers Biomedical and Health Sciences United States 2024 – 2029

Project Summary/Abstract Severe storms, whether hurricanes or other storms with significant wind/precipitation, affect millions of Americans each year, disrupt the delivery of heal...

$2.49M
USD
Active NON-SBIR/STTR RPGS
The role of tumor-macrophage hybrid cells in prostate cancer metastasis
NATIONAL CANCER INSTITUTE University of Texas Hlth Science Center United States 2024 – 2029

ABSTRACT The role of tumor-macrophage hybrid cells in prostate cancer metastasis AR signaling inhibitors (ARSIs) are commonly used to treat recurrent prostate cancer whose growth d...

$6.37M
USD
Completed TRAINING, INDIVIDUAL
Synthesis and design of macrocyclic collagen mimetic peptides for targeting the cancer-implicated DDR2 kinase
NATIONAL CANCER INSTITUTE University of Pennsylvania United States 2024 – 2025

Project Summary / Abstract Collagen lays the foundation of bodily tissues, serving to strengthen, connect, and signal from the micro to the macro scale. The importance of collagen...

$366.6K
USD
Completed NON-SBIR/STTR RPGS
Contribution of Cellular and Molecular Heterogeneity of Esophageal Epithelium to Health Disparities in Esophageal Cancer
NATIONAL CANCER INSTITUTE Temple University of the Commonwealth United States 2024 – 2024

Project Summary Esophageal cancer is one of the most aggressive forms of human malignancy. Esophageal squamous cell carcinoma (ESCC) and esophageal adenocarcinoma (EAC) are the pri...

$10
USD
Active NON-SBIR/STTR RPGS
Strategies for Personalizing Oxygen and support Therapies for dyspnea in Oncology
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2024 – 2029

PROJECT SUMMARY Dyspnea is one of the most common and distressing symptoms associated with cancer, occurring in nearly 70% of patients with advanced cancer. Dyspnea is associated w...

$6.55M
USD
Active NON-SBIR/STTR RPGS
Targeting the gut microbiome to inhibit melanoma lymph node metastases
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2024 – 2028

PROJECT SUMMARY Melanoma is a devastating skin cancer that kills nearly 8,000 patients in the US annually. Patients with thicker melanomas, invading deeper and closer to lymphatics...

$5.31M
USD
Completed TRAINING, INDIVIDUAL
Development of novel CYP8B1 inhibitors
NATIONAL CANCER INSTITUTE Beckman Research Institute/City of Hope United States 2024 – 2025

Project Summary Hepatocellular carcinoma (HCC) is a highly lethal cancer, and obesity is associated with an 89% increased risk of HCC. Because of the need for safer and more effect...

$742.8K
USD
Active NON-SBIR/STTR RPGS
Dual Use Cessation: A MOST Screening Trial to Identify Effective Interventions to Help People Who Smoke and Vape
NATIONAL CANCER INSTITUTE University of Wisconsin-Madison United States 2024 – 2029

PROJECT SUMMARY Over the past decade, dual use of combustible cigarettes and electronic cigarettes (e-cigarettes) has risen substantially. The evidence is mixed as to whether this...

$8.76M
USD
Active NON-SBIR/STTR RPGS
Ribonucleotide Processing in Telomere Maintenance and Integrity
NATIONAL CANCER INSTITUTE University of Kansas Medical Center United States 2024 – 2029

Abstract Chromosomal ends harbor repetitive DNA sequences, termed telomeres, that are recognized by the shelterin complex to form a lariat structure called the T-loop, which protec...

$5.05M
USD